These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30822817)

  • 1. [Expenditures of The German Statutory Health Insurance for Health Promotion and Disease Prevention 2012-2017: Positive Effects Due To The Disease Prevention Law?].
    Bödeker W; Moebus S
    Gesundheitswesen; 2020 Mar; 82(3):282-287. PubMed ID: 30822817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Public expenditure caused by the consumption of illicit drugs in Germany].
    Mostardt S; Flöter S; Neumann A; Wasem J; Pfeiffer-Gerschel T
    Gesundheitswesen; 2010 Dec; 72(12):886-94. PubMed ID: 20066613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary analysis of short-term financial implications of a prevention bonus program: first results from the German Statutory Health Insurance.
    Stock S; Stollenwerk B; Klever-Deichert G; Redaelli M; Büscher G; Graf C; Möhlendick K; Mai J; Gerber A; Lüngen M; Lauterbach KW
    Int J Public Health; 2008; 53(2):78-86. PubMed ID: 18681336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the medical expenditure of the basic health insurance in Morocco.
    Yassine A; Hangouche AJ; El Malhouf N; Maarouf S; Taoufik J
    Pan Afr Med J; 2020; 35():115. PubMed ID: 32637013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in health care expenditure associated with gaining or losing health insurance.
    Ward L; Franks P
    Ann Intern Med; 2007 Jun; 146(11):768-74. PubMed ID: 17548408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk structure compensation in Germany's statutory health insurance.
    Busse R
    Eur J Public Health; 2001 Jun; 11(2):174-7. PubMed ID: 11420805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention and health promotion as a responsibility of legal health insurance--exemplified by a local insurance bureau].
    Ollenschläger G; Denecke A
    Gesundheitswesen; 1994; 56(8-9):423-9. PubMed ID: 8000163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factors Influencing Participation in Financial Incentive Programmes of Health Insurance Funds. Results of the Study 'German Health Update'].
    Jordan S; von der Lippe E; Starker A; Hoebel J; Franke A
    Gesundheitswesen; 2015 Nov; 77(11):861-8. PubMed ID: 25536225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personal responsibility for health--developments under the German Healthcare Reform 2007.
    Schmidt H
    Eur J Health Law; 2007 Nov; 14(3):241-50. PubMed ID: 18229761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Conflicting Rules and Incentives for Health Promotion and Prevention in the German Statutory Health Insurance (GKV)].
    Bödeker W; Moebus S
    Gesundheitswesen; 2015 Jun; 77(6):397-404. PubMed ID: 25111361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Work place health promotion programmes of the statutory German Pension Insurance].
    Meffert C; Mittag O; Jäckel WH
    Rehabilitation (Stuttg); 2013 Dec; 52(6):391-8. PubMed ID: 24217885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Participant structure and economic benefit of prevention bonus programmes in company health insurance funds].
    Friedrichs M; Friedel H; Bödeker W
    Gesundheitswesen; 2009 Oct; 71(10):623-7. PubMed ID: 19885763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determinants of income and expenditure development in the annual reports of the health insurance of the Federal Republic of Germany].
    Jacobs K
    Soz Praventivmed; 1989; 34(6):256-9. PubMed ID: 2514523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expenditures of the German statutory health insurance system for patients suffering from acute coronary syndrome and treated with percutaneous coronary intervention.
    Friedel H; Delges A; Clouth J; Trautvetter DT
    Eur J Health Econ; 2010 Oct; 11(5):449-55. PubMed ID: 19774404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural changes in the German pharmaceutical market: price setting mechanisms based on the early benefit evaluation.
    Henschke C; Sundmacher L; Busse R
    Health Policy; 2013 Mar; 109(3):263-9. PubMed ID: 23339876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oregon Medicaid Expenditures After the 2014 Affordable Care Act Medicaid Expansion: Over-time Differences Among New, Returning, and Continuously Insured Enrollees.
    Springer R; Marino M; O'Malley JP; Lindner S; Huguet N; DeVoe JE
    Med Care; 2018 May; 56(5):394-402. PubMed ID: 29578955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.
    Leung GM; Tin KY; Yeung GM; Leung ES; Tsui EL; Lam DW; Tsang CS; Fung AY; Lo SV
    Hong Kong Med J; 2008 Apr; 14 Suppl 2():2-23. PubMed ID: 18587162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of disease prevention in a morbidity-based financing system: does prevention pay off for a statutory health insurance fund in Germany?
    Weinhold I; Schindler C; Kossack N; Berndt B; Häckl D
    Eur J Health Econ; 2019 Nov; 20(8):1181-1193. PubMed ID: 31317353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of out-of-pocket expenditure and catastrophic health expenditure for severe disease by the health security system: based on end-stage renal disease in South Korea.
    Shin SM; Lee HW
    Int J Equity Health; 2021 Jan; 20(1):6. PubMed ID: 33407535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.